← H20

Chapter 7 - Diseases of the eye and adnexa (H00-H59)»Disorders of sclera, cornea, iris and ciliary body (H15-H22)»Unspecified iridocyclitis (H20.9)

H20.9

Unspecified iridocyclitis

Related indications (MeSH) (4)

Iridocyclitis4 drugs (4 approved)

Acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil. Symptoms include radiating pain, photophobia, lacrimation, and interference with vision.

Panuveitis13 drugs (11 approved, 2 experimental)

Inflammation in which both the anterior and posterior segments of the uvea are involved and a specific focus is not apparent. It is often severe and extensive and a serious threat to vision. Causes include systemic diseases such as tuberculosis, sarcoidosis, and syphilis, as well as malignancies. The intermediate segment of the eye is not involved.

Uveitis79 drugs (54 approved, 25 experimental)

Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)

Uveitis, Anterior32 drugs (27 approved, 5 experimental)

Inflammation of the anterior uvea comprising the iris, angle structures, and the ciliary body. Manifestations of this disorder include ciliary injection, exudation into the anterior chamber, iris changes, and adhesions between the iris and lens (posterior synechiae). Intraocular pressure may be increased or reduced.